Form 4 for BDSX BIODESIX INC
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0001140361-22-012922 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-04 | 2022-03-31 | BDSX | Franchi Jean M. | Dir | M - OptEx | — | +20.0K | 20.0K | New | — |
| D | 2022-04-04 | 2022-03-31 | BDSX | Franchi Jean M. | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | M | A | 20,044 | — | 20,044 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Derivative | Restricted Stock Units | 2022-03-31 | M | D | 20,044 | $0.00 | 0 | D | — · — to — | 20,044 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F2) These restricted stock units vested in full on March 31, 2022 and had no expiration date. |